# Big Vision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/big-vision

- Industry: Healthcare
- Headquarters: Suzhou, China
- Website: www.bigvisiontech.com
- Latest round: Series B (Jun 1, 2026)
- Investors on record: 3

## About

Based in Suzhou, China and founded in 2015, Suzhou Big Vision Medical Technology Co., Ltd., trading as Big Vision, is a medical technology company that focuses on the research and development of ophthalmic disease diagnosis and analysis system. In June 2026, Big Vision raised a Series B+ funding from Lanwan Venture Capital.

The company engages in the research and development of ophthalmic disease diagnosis and analysis systems. Based on an ophthalmic AI-assisted diagnostic system, it uses AI-integrated ophthalmic OCT hardware as its market entry point to provide intelligent system solutions for eye health medical and service units such as primary hospitals, physical examination centers, and optometry centers. It also provides comprehensive one-stop eye health management services for individual users, focusing on eye health data centered on imaging.

The company generates revenue by providing comprehensive one-stop eye health management services and selling its proprietary artificial intelligence-assisted diagnostic systems and OCT hardware devices.

## Funding rounds

- Series B, Jun 1, 2026 — Lanwan Venture Capital
- Series A, Dec 16, 2021 — SND Ventures Group, Agriculture Development Innovation Capital

## Investors

- SND Ventures Group (https://capitalatlas.ai/funds/snd-ventures-group) — Series A
- Agriculture Development Innovation Capital (https://capitalatlas.ai/funds/agriculture-development-innovation-capital) — Series A
- Lanwan Venture Capital (https://capitalatlas.ai/funds/lanwan-venture-capital) — Series B